Based on the fact that EMT is one of the mechanisms of drug resistance in tumor cells, our team conducted a preliminary study on the molecular probe of tumor drug resistance by using the principle of specific binding of ADH-1 to N-cadherin, one of the mesenchymal landmark proteins. Here, CDH2 is linked to neoplasm.